NASDAQ: OCX - OncoCyte Corporation

Lønnsomhet i seks måneder: +2.76%
Sektor: Healthcare

Kampanjeplan OncoCyte Corporation

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

OncoCyte Corporation, a molecular diagnostics company, research, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, biopharma, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies.

Flere detaljer
The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

Выручка 1.6E-5
EBITDA -0.0217
Число акций ао 0.1108 млрд
P/S 7726.46
P/BV 18.24
EV/EBITDA -4.96
Цена ао 3
ISIN US68235C1071
Сайт https://oncocyte.com
Валюта usd
IPO date 2016-01-04
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Prisendring per dag: -2.3% (3.05)
Prisendring per uke: +0.3367% (2.97)
Prisendring per måned: -6.58% (3.19)
Prisendring over 3 måneder: -1.65% (3.03)
Prisendring over seks måneder: +2.76% (2.9)
Prisendring per år: -5.4% (3.15)
Prisendring over 3 år: -25.5% (4)
Prisendring over 5 år: +49.75% (1.99)
Prisendring siden begynnelsen av året: +7.19% (2.78)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 13.18 1
P/BV 0.7742 9
P/E 0 0
EV/EBITDA -0.6515 0
Total: 4.88

Effektivitet

Navn Betydning Karakter
ROA, % -37.09 0
ROE, % -108.54 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.141 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 9293.75 10
Lønnsomhet Ebitda, % -6.25 0
Lønnsomhet EPS, % -58.31 0
Total: 3.4
Flere detaljer

Institusjoner Volum Dele, %
Broadwood Capital, Inc. 2509066 30.37
AWM Investment Company, Inc. 754286 9.13
PURA VIDA INVESTMENTS, LLC 586930 7.11
Vanguard Group Inc 247873 3
Morgan Stanley 122973 1.49
Defender Capital, LLC 71650 0.87
Geode Capital Management, LLC 61482 0.74
Blackrock Inc. 60187 0.73
State Street Corporation 16289 0.2
Renaissance Technologies, LLC 12718 0.15

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00668 34.327031588619 1.54048



Veileder Stillingstittel Betaling Fødselsår
Mr. Joshua Riggs President, CEO & Director 504.63k 1983 (41 år)
Mr. James Liu Senior Director, Controller & Principal Accounting Officer 259.83k 1996 (28 år)
Dr. Ekkehard Schutz M.D., Ph.D. Chief Science Officer 409.27k
Mr. Yuh-Min Chiang Ph.D. Chief Technology Officer N/A
Dr. Michael D. West Ph.D. Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc. N/A 1953 (71 år)
Mr. Peter Hong VP, General Counsel & Secretary N/A
Ms. Andrea Susan James Chief Financial Officer
Ms. Sandra O'Donald Senior Vice President of Business Operations

Adresse: United States, Irvine. CA, 15 Cushing - åpne i Google maps, åpne Yandex-kart
Nettsted: https://oncocyte.com